820 results on '"Kümmel, S."'
Search Results
2. EFFECT OF DIBUTYLTIN DICHLORIDE ON LIPASE AND AMYLASE ACTIVITY IN SERUM AND PANCREAS OF RATS
3. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
4. Traditionelle chinesische Medizin in der integrativen Onkologie
5. Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial
6. On the challenge to improve the density response with unusual gradient approximations
7. Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
8. Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
9. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
10. Coordination-driven magnetic-to-nonmagnetic transition in manganese doped silicon clusters
11. A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
12. Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto
13. Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?
14. Electrical response of molecular systems: the power of self-interaction corrected Kohn-Sham theory
15. Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study
16. Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany
17. Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients
18. Collectivity in the optical response of small metal clusters
19. Quantum fluid-dynamics from density functional theory
20. Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres
21. De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel
22. Ionic and electronic structure of sodium clusters up to N=59
23. Thermal expansion in small metal clusters and its impact on the electric polarizability
24. Static Electric Dipole Polarizabilities of Na Clusters
25. P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
26. Standards in der adjuvanten Systemtherapie des Mammakarzinoms
27. Ionic structure and photoabsorption in medium sized sodium clusters
28. Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
29. Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer
30. Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
31. Enrichment of ANME-2 Dominated Anaerobic Oxidation of Methane Coupled to Sulfate Reduction Consortia from Cold Seep Sediment (Ginsburg Mud Volcano, Gulf of Cadiz) in a Membrane Bioreactor
32. Underestimated risk of involved margins in Skin (SMM)- and Nipple Sparing Mastectomies (NSM) – Data and Multimodal Approach for Improvement
33. AI-based smartphone App using a single-lead ECG for automated QTc diagnostics in oncology
34. Mesh-Pocket Supported Prepectoral Direct-to-Implant Breast Reconstruction: Preliminary Results of a Prospective Analysis
35. Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress
36. Analyzing Excitation-Energy Transfer Based on the Time-Dependent Density Functional Theory in Real Time
37. 196P Efficacy and safety of first-line (1L) ribociclib (RIB) + letrozole (LET) in patients (pts) with de novo metastatic disease and late recurrence from (neo)adjuvant therapy (tx) in MONALEESA (ML)-2
38. 120TiP Premenopausal women with breast cancer optimally treated with OFS (PROOFS)
39. 18P A translational project of the WSG-ADAPT-TN trial demonstrates immunomodulatory and anti-viral defense gene networks predicting pathological complete response (pCR) and survival after de-escalated neoadjuvant chemotherapy (NACT) in early triple-negative breast cancer (eTNBC)
40. Lebensstilfaktoren und Komplementärmedizin beim Mammakarzinom
41. Mind-Body-Medizin in der integrativen Onkologie: Studienlage und Einsatzgebiete
42. Using the framework of corporate culture in “mergers” to support the development of a cultural basis for integrative medicine – guidance for building an integrative medicine department or service
43. Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”
44. Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
45. Standards in der adjuvanten Systemtherapie des Mammakarzinoms
46. Mesh-pocket supported prepectoral direct-to-implant breast reconstruction: preliminary results of a prospective analysis
47. Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO–AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy
48. Frequencies, times, and forces in the dynamics of Na clusters
49. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients
50. A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.